Delivery Order SPE2DB20D3103-SPE2DB23FL9D7
- Not listed
- This federal contract award, valued at $14,850.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product JARDIANCE 10 MG TABLET 90S, with a completion date of November 9, 2023. The contract is a firm fixed-price arrangement and was awarded without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that...
- This federal contract award, valued at $3,755.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of March 23, 2023. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
- This federal contract award, valued at $1,508.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of 4563171498 - JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract, with an ultimate completion date of December 26, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $10,999.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 25, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $17,579.29 for the supply of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract is a Firm Fixed Price agreement, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This federal contract award, valued at $13,401.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the supply of JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 1, 2024 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,369.96 for the supply of JARDIANCE 25 MG TABLET 90S. The award is part of a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,253.98, is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of November 2, 2023. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant...
- This federal contract award, valued at $2,933.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of May 3, 2023. The contract was awarded on May 2, 2023, and there was no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract, valued at $40,945.51, is a delivery order for 4562852729 JARDIANCE 10 MG TABLET 90S, a pharmaceutical product. The contract has a ceiling value of $40,945.51 and an ultimate completion date of November 20, 2023. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL9D7Delivery Order
This federal contract award, valued at $26,680.63, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of JARDIANCE 25 MG TABLET 90S, a pharmaceutical product, with a completion date of December 16, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA). The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.7k | 12/15/22 |